Cargando…
The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review
BACKGROUND: Inconsistent and unequal access to medical care is an issue that predates the COVID19 pandemic, which only worsened the problem. Limited access to care from asthma specialists and other specialists treating comorbid diseases may adversely affect asthma. OBJECTIVE: The purpose of this rev...
Autores principales: | Codispoti, Christopher D., Greenhawt, Matthew, Oppenheimer, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353043/ https://www.ncbi.nlm.nih.gov/pubmed/35525532 http://dx.doi.org/10.1016/j.jaip.2022.04.025 |
Ejemplares similares
-
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
por: Shaker, Marcus S., et al.
Publicado: (2020) -
Estimation of Health and Economic Benefits of a Small Automatic External Defibrillator for Rapid Treatment of Sudden Cardiac Arrest (SMART): A Cost-Effectiveness Analysis
por: Shaker, Marcus S., et al.
Publicado: (2022) -
Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019) -
Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction
por: Greenhawt, Matthew, et al.
Publicado: (2019) -
Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2018)